Immediate Impact
62 standout
Citing Papers
Current and future immunotherapeutic approaches in pancreatic cancer treatment
2024 Standout
Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours
2024 Standout
Works of E Procaccini being referenced
Three dimensional primary cultures for selecting human breast cancers that are sensitive to the anti-tumor activity of ipatasertib or taselisib in combination with anti-microtubule cytotoxic drugs
2018
Neutrophil to lymphocyte ratio (NLR) for prediction of distant metastasis-free survival (DMFS) in early breast cancer: a propensity score-matched analysis
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| E Procaccini | 183 | 89 | 153 | 93 | 25 | 416 | |
| Giulia Ferrarazzo | 141 | 175 | 104 | 190 | 25 | 501 | |
| Qin Zhou | 87 | 104 | 114 | 81 | 38 | 413 | |
| Giuseppe Carlo Iorio | 98 | 122 | 118 | 91 | 43 | 403 | |
| Eisaku Ito | 169 | 147 | 153 | 142 | 33 | 511 | |
| Raffaele Solla | 94 | 118 | 158 | 131 | 24 | 466 | |
| Jin Gu | 91 | 84 | 164 | 53 | 33 | 393 | |
| Jen‐Pin Chuang | 133 | 71 | 207 | 49 | 24 | 391 | |
| L. Busutti | 209 | 83 | 117 | 56 | 28 | 482 | |
| C Menzel | 83 | 85 | 81 | 108 | 30 | 468 | |
| Taro Tanabe | 129 | 117 | 301 | 75 | 25 | 460 |
All Works
Loading papers...